Product Information

DEXMETHYLPHENIDATE ER 25 MG CP is a generic product labeled by Granules Pharmaceuticals Inc., priced at $1.7460 per EA under NDC 70010000801. Its NADAC has been published 289 times since Feb 10, 2021.

FDA first approved this application on Sep 9, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXMETHYLPHENIDATE ER 25 MG CP

DEXMETHYLPHENIDATE HYDROCHLORIDE
$1.7460per EA
DEA Schedule CII

Strength

25 mg/1

NDC

70010000801

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213813

FDA Approved

9/9/2020

TE Code

AB

On Market Since

12/1/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXMETHYLPHENIDATE ER 25 MG CP has been published 289 times since Feb 10, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.7460 per EA
All-time high$2.7181 (Jul 12, 2023)
All-time low$1.2360 (May 22, 2024)
52-week high$2.2297
52-week low$1.6645
Median price$2.0878
Average price$2.0572
Largest weekly change+109.4% (Jun 19, 2024)
Weeks tracked289
Tracking sinceFeb 10, 2021

Price History

1W

-10.7%

1M

-10.7%

3M

-21.7%

6M

-11.8%

1Y

+4.9%

3Y

-21.4%

5Y

-28.6%

All

-0.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXMETHYLPHENIDATE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of DEXMETHYLPHENIDATE ER 25 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 25 MG CP, manufactured by Granules Pharmaceuticals Inc., is $1.7460 per EA (NDC 70010000801), effective Aug 19, 2026.

How has the price of DEXMETHYLPHENIDATE ER 25 MG CP changed over time?

Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 25 MG CP has held within roughly two percent of its current level. It has been tracked across 289 weekly CMS publications since Feb 10, 2021.

What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 25 MG CP?

Since Feb 10, 2021, the NADAC for DEXMETHYLPHENIDATE ER 25 MG CP has ranged from a low of $1.2360 (May 22, 2024) to a high of $2.7181 (Jul 12, 2023), with a median of $2.0878 per EA.

Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 25 MG CP?

No other NADAC-published product currently shares the active ingredient and strength of DEXMETHYLPHENIDATE ER 25 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DEXMETHYLPHENIDATE ER 25 MG CP?

DEXMETHYLPHENIDATE ER 25 MG CP (NDC 70010000801) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.